Blood News and Research

RSS

Targeted Medical Pharma signs agreement with Lebanon based company, ATL

Targeted Medical Pharma, today announced the completion of an agreement between Analytical Testing Laboratories (ATL), a Lebanon based company that specializes in drug testing services and inborn errors of metabolism, for the exclusive distribution of the company's amino acid based products to physicians and pharmacies throughout the Middle East.

17 Apr 2014

Entries now open for 2014 Quality in Care Hepatitis C programme

The first Quality in Care (QiC) Hepatitis C programme is now open for entry to teams and individuals working within the field of hepatitis C.

17 Apr 2014

Research on HIV and schistosomiasis coinfection in sub-Saharan Africa children

Paper shows that more work is needed to fully understand the consequences of coinfection. Researchers from LSTM have called for more research to be carried out into HIV and schistosomiasis coinfection in children in sub-Saharan Africa.

17 Apr 2014

Boehringer grants volasertib 'orphan drug designation' for treatment of patients with AML

Boehringer Ingelheim announced today that the US Food and Drug Administration (FDA) and the European Commission have granted volasertib* 'orphan drug designation' for the treatment of patients with acute myeloid leukaemia (AML).

17 Apr 2014

Researchers uncover mechanism that may help explain severe forms of schistosomiasis

Researchers at the Sackler School of Graduate Biomedical Sciences at Tufts and Tufts University School of Medicine (TUSM) have uncovered a mechanism that may help explain the severe forms of schistosomiasis, or snail fever, which is caused by schistosome worms and is one of the most prevalent parasitic diseases in the world. The study in mice, published online in The Journal of Immunology, may also offer targets for intervention and amelioration of the disease.

17 Apr 2014

Scientists discover protein structure that helps common fungal pathogen to infect humans

A team that includes scientists from the School of Medicine at The University of Texas Health Science Center at San Antonio, Johns Hopkins University and St. Mary's University reported the structure of a protein that helps a common fungus to infect the body.

17 Apr 2014

Delayed umbilical cord clamping is effective even when newborn is placed on mother's abdomen

A recent study has shown that a newborn benefits from delayed cord clamping even when placed immediately on the mother's abdomen.

17 Apr 2014

Massage therapy alleviates muscle soreness and improves general blood flow

Massage therapy improves general blood flow and alleviates muscle soreness after exercise, according to a study by researchers at the University of Illinois at Chicago.

17 Apr 2014

Researchers develop novel tools to learn how astrocytes listen in on neuronal communication

Everything we do - all of our movements, thoughts and feelings - are the result of neurons talking with one another, and recent studies have suggested that some of the conversations might not be all that private.

17 Apr 2014

Freiburg researchers discover molecule that smuggles toxins from intestinal pathogens into human cells

Prof. Dr. Dr. Klaus Aktories and Dr. Panagiotis Papatheodorou from the Institute of Experimental and Clinical Pharmacology and Toxicology of the University of Freiburg have discovered the receptor responsible for smuggling the toxin of the bacterium Clostridium perfringens into the cell.

17 Apr 2014

Professor from INRS receives NIH grant to explore biomedical potential in field of oncology

Professor Nicolas Doucet of the Centre INRS-Institut Armand-Frappier has just received a research grant from the National Institutes of Health (NIH) in the amount of nearly US$600,000. The 5-year grant is to pursue cutting-edge research in the workings of tiny proteins called RNases and to explore their biomedical potential in the field of oncology as well as in inflammation and asthma.

17 Apr 2014

Scientists trying to merge millions of patient medical records

The attempt includes collecting and connecting terabytes of patient medical records from every patient recently treated at one of New York's major hospital centers. Meanwhile in Kansas, a council discusses ways to regulate so-called "secondary use" of patient health data.

16 Apr 2014

Iconic Therapeutics completes $20 million Series B-1 equity financing

Iconic Therapeutics, Inc., a biotechnology company focused on developing therapeutics for serious eye disorders, announced today that it has successfully completed a $20 million Series B-1 equity financing from new investors MPM Capital, Lundbeckfond Ventures, and H.I.G. BioVentures.

16 Apr 2014

Baxter reports topline results from BAX 111 Phase 3 trial for treatment of von Willebrand disease

Baxter International Inc. today announced topline results from a Phase 3 clinical trial evaluating the safety, efficacy and pharmacokinetics (PK) of BAX 111. BAX 111 is a recombinant von Willebrand factor (rVWF) under investigation for the treatment of bleeding episodes in patients with von Willebrand disease, the most common type of inherited bleeding disorder.

From Baxter International Inc. 16 Apr 2014

First Edition: April 16, 2014

Today's headlines include a report detailing how changes in the Census Bureau's annual survey could mask the health law's impact.

16 Apr 2014

Combination therapy could help prevent cardiovascular disease

Taking one pill instead of three could be a powerful ally to prevent cardiovascular disease, according to a new Cochrane systematic review of the latest research on polypills from a team of scientists at the London School of Hygiene & Tropical Medicine, Warwick Medical School and Northwestern Medicine.

16 Apr 2014

Scientists report new approach to restore penicillin's combat effectiveness against bacterial infections

Penicillin, one of the scientific marvels of the 20th century, is currently losing a lot of battles it once won against bacterial infections. But scientists at the University of South Carolina have just reported a new approach to restoring its combat effectiveness, even against so-called "superbugs."

16 Apr 2014

Harvard successfully transplants regenerated esophagus into rat using bioreactor

Harvard Apparatus Regenerative Technology, Inc., a clinical stage biotechnology company developing regenerated organs for transplant, initially focused on the trachea, announces that a research team led by Paolo Macchiarini, MD, PhD at Karolinska Institutet in Sweden has successfully transplanted a regenerated esophagus into a rat using a bioreactor developed by HART.

16 Apr 2014

Multifunctional microcapsules can be produced from tannic acid and metals

Microcapsules with a broad spectrum of applications in biomedicine, catalysis, and technology can be produced by using plant-derived, phenolic tannic acid and a variety of metals. The capsules are formed by a simple self-assembly process, and their properties can be controlled through the choice of metal, as demonstrated by a team of Australian and German researchers in the journal Angewandte Chemie.

16 Apr 2014

Dental researchers find new way to study how mouth's natural defenses ward off infection, inflammation

Case Western Reserve University dental researchers have found a less invasive way to extract single rare immune cells from the mouth to study how the mouth's natural defenses ward off infection and inflammation.

16 Apr 2014

Blood News and Research

Targeted Medical Pharma signs agreement with Lebanon based company, ATL

Entries now open for 2014 Quality in Care Hepatitis C programme

Research on HIV and schistosomiasis coinfection in sub-Saharan Africa children

Boehringer grants volasertib 'orphan drug designation' for treatment of patients with AML

Researchers uncover mechanism that may help explain severe forms of schistosomiasis

Scientists discover protein structure that helps common fungal pathogen to infect humans

Delayed umbilical cord clamping is effective even when newborn is placed on mother's abdomen

Massage therapy alleviates muscle soreness and improves general blood flow

Researchers develop novel tools to learn how astrocytes listen in on neuronal communication

Freiburg researchers discover molecule that smuggles toxins from intestinal pathogens into human cells

Professor from INRS receives NIH grant to explore biomedical potential in field of oncology

Scientists trying to merge millions of patient medical records

Iconic Therapeutics completes $20 million Series B-1 equity financing

Baxter reports topline results from BAX 111 Phase 3 trial for treatment of von Willebrand disease

First Edition: April 16, 2014

Combination therapy could help prevent cardiovascular disease

Scientists report new approach to restore penicillin's combat effectiveness against bacterial infections

Harvard successfully transplants regenerated esophagus into rat using bioreactor

Multifunctional microcapsules can be produced from tannic acid and metals

Dental researchers find new way to study how mouth's natural defenses ward off infection, inflammation

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News